NCT02909465View on ClinicalTrials.gov

Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation

PHASE4CompletedINTERVENTIONAL

Enrollment

185

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

July 31, 2017

Conditions

Ketamine Induced Agitation

Interventions

DRUG

Midazolam

Using Midazolam as a premedication for reducing ketamine-induced agitation

DRUG

Haloperidol

Using Haloperidol as a premedication for reducing ketamine-induced agitation

DRUG

placebo

distilled water

DRUG

Ketamine

Ketamine is routinely used for all procedural sedation in the patients.

Trial Locations (1)

Unknown

Sina Hospital, Tehran

All Listed Sponsors

lead

Tehran University of Medical Sciences

OTHER

NCT02909465 - Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation | Biotech Hunter | Biotech Hunter